Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Shands Jacksonville / University of Florida
mi
from
Jacksonville, FL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Shands Jacksonville / University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
OCALA Neurodiagnostic Center
mi
from
Ocala, FL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
OCALA Neurodiagnostic Center
mi
from
Ocala, FL
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Florida Hospital Neuroloscience Institute
mi
from
Orlando, FL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Florida Hospital Neuroloscience Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Fawcett Memorial Hospital
mi
from
Port Charlotte, FL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Fawcett Memorial Hospital
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Peace River Regional Medical Center
mi
from
Port Charlotte, FL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Peace River Regional Medical Center
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Tallahassee Memorial Healthcare
mi
from
Tallahassee, FL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Tallahassee Memorial Healthcare
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
The Queens Medical Center, Neuroscience Institute
mi
from
Honolulu, HI
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
The Queens Medical Center, Neuroscience Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Mercy Hospital
mi
from
Chicago, IL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Mercy Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Elkhart Clinic, LLC - Neurology
mi
from
Elkhart, IN
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Elkhart Clinic, LLC - Neurology
mi
from
Elkhart, IN
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Fort Wayne Neurological Center
mi
from
Fort Wayne, IN
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Fort Wayne Neurological Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Parkview Research Center
mi
from
Fort Wayne, IN
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Parkview Research Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Baystate Medical Center
mi
from
Springfield, MA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Wayne State University
mi
from
Detroit, MI
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
St. Mary's Duluth Clinic
mi
from
Duluth, MN
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
St. Mary's Duluth Clinic
mi
from
Duluth, MN
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Minneapolis Clinic of Neurology
mi
from
Golden Valley, MN
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Minneapolis Clinic of Neurology
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Deaconess Billings Clinical Research Center
mi
from
Billings, MT
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Deaconess Billings Clinical Research Center
mi
from
Billings, MT
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
NJ Neuroscience Institute
mi
from
Edison, NJ
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
NJ Neuroscience Institute
mi
from
Edison, NJ
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Neurology Consultants of Burlington County
mi
from
Lumberton, NJ
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Neurology Consultants of Burlington County
mi
from
Lumberton, NJ
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Neurology Group of Bergen County
mi
from
Ridgewood, NJ
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Neurology Group of Bergen County
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Shore Neurology
mi
from
Toms River, NJ
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Shore Neurology
mi
from
Toms River, NJ
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Kaleida Stroke Center
mi
from
Buffalo, NY
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Kaleida Stroke Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
United Health Services Hospitals
mi
from
Johnson City, NY
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
United Health Services Hospitals
mi
from
Johnson City, NY
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Winthrop University Hospital
mi
from
Minneola, NY
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Winthrop University Hospital
mi
from
Minneola, NY
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Weill Medical College of Cornell University
mi
from
New York, NY
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Rochester General Hospital
mi
from
Rochester, NY
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Strong Memorial Hospital
mi
from
Rochester, NY
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Strong Memorial Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Presbyterian Hospital
mi
from
Charlotte, NC
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Presbyterian Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Lebauer Cardiovascular Research Foundation at Moses Cone Hospital
mi
from
Greensboro, NC
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Lebauer Cardiovascular Research Foundation at Moses Cone Hospital
mi
from
Greensboro, NC
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Clinical Research of Winston-Salem
mi
from
Winston-Salem, NC
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Clinical Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Toledo Hospital
mi
from
Toledo, OH
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Medical University of Ohio
mi
from
Toledo, OH
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Medical University of Ohio
mi
from
Toledo, OH
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Northshore Clinical Associates
mi
from
Erie, PA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Northshore Clinical Associates
mi
from
Erie, PA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Westmoreland Neurology Associates, Inc.
mi
from
Greensburg, PA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Westmoreland Neurology Associates, Inc.
mi
from
Greensburg, PA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Miriam Hospital
mi
from
Providence, RI
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Beaufort Memorial Hospital
mi
from
Beaufort, SC
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Beaufort Memorial Hospital
mi
from
Beaufort, SC
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Methodist University Hospital
mi
from
Memphis, TN
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Methodist University Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Brackenridge Hospital
mi
from
Austin, TX
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Brackenridge Hospital
mi
from
Austin, TX
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Seton Medical Center
mi
from
Austin, TX
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Seton Medical Center
mi
from
Austin, TX
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Methodist Hospital - The Neurological Institute
mi
from
Houston, TX
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Methodist Hospital - The Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Virginia Commonwealth University
mi
from
Richmond, VA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Neurological Consultants of Virginia Beach
mi
from
Virginia Beach, VA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Neurological Consultants of Virginia Beach
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Harborview Medical Center
mi
from
Seattle, WA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Madigan Army Medical Center
mi
from
Tacoma, WA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
St. Luke's Medical Center
mi
from
Milwaukee, WI
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Medical College of Wisconsin
mi
from
Milwaukee, WI
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
Gosford Hospital Department of Neurology
mi
from
Gosford,
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Gosford Hospital Department of Neurology
mi
from
Gosford,
Click here to add this to my saved trials
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Status: Enrolling
Updated:  12/23/2009
UCLA
mi
from
Los Angeles, CA
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Status: Enrolling
Updated: 12/23/2009
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials